Cargando…

A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol

BACKGROUND: Patients with haematologic malignancies are increasingly treated by oral anticancer medications, heightening the challenge of ensuring optimal adherence to treatment. However, except for chronic myelogenous leukaemia or acute lymphoid leukaemia, the extent of non-adherence has rarely bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Michiels, Sandra, Tricas-Sauras, Sandra, Dauvrin, Marie, Bron, Dominique, Kirakoya-Samadoulougou, Fati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224871/
https://www.ncbi.nlm.nih.gov/pubmed/34166438
http://dx.doi.org/10.1371/journal.pone.0253526
_version_ 1783711972186914816
author Michiels, Sandra
Tricas-Sauras, Sandra
Dauvrin, Marie
Bron, Dominique
Kirakoya-Samadoulougou, Fati
author_facet Michiels, Sandra
Tricas-Sauras, Sandra
Dauvrin, Marie
Bron, Dominique
Kirakoya-Samadoulougou, Fati
author_sort Michiels, Sandra
collection PubMed
description BACKGROUND: Patients with haematologic malignancies are increasingly treated by oral anticancer medications, heightening the challenge of ensuring optimal adherence to treatment. However, except for chronic myelogenous leukaemia or acute lymphoid leukaemia, the extent of non-adherence has rarely been investigated in outpatient settings, particularly for migrant population. With growing numbers of migrants in Belgium, identifying potential differences in drug use is essential. Also, previous research regarding social determinants of health highlight important disparities for migrant population. Difficulties in communication between health caregivers and patients from different cultural and ethnic backgrounds has been underlined. METHODS: Using a sequential mixed method design, the MADESIO protocol explores the adherence to oral anticancer medications in patients with haematological malignancies and among first and second generation migrants of varied origin. Conducted in the ambulatory setting, a first quantitative strand will measure adherence rates and associated risk factors in two sub-groups of patients with haematological malignancies (group A: first and second generation migrants and group B: non-migrants). The second qualitative strand of this study uses semi-structured interviews to address address the patients’ subjective meanings and understand the statistical associations observed in the quantitative study (strand one). MADESIO aims to provide a first assessment of whether and why migrants constitute a population at risk concerning adherence to oral anticancer medications. DISCUSSION: Our protocol is designed to provide a comprehensive understanding of adherence in a specific population. The methodological choices applied allow to explore adherence among patients from diverse linguistic and cultural backgrounds. A particular emphasis has been paid to minimize the biases and increase the reliability of the data collected. Easily reproductible, the MADESIO design may help healthcare services to screen adherence to Oral anticancer medications and to guide providers in choosing the best strategies to address medication adherence of migrants or minority diverse population.
format Online
Article
Text
id pubmed-8224871
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-82248712021-07-19 A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol Michiels, Sandra Tricas-Sauras, Sandra Dauvrin, Marie Bron, Dominique Kirakoya-Samadoulougou, Fati PLoS One Study Protocol BACKGROUND: Patients with haematologic malignancies are increasingly treated by oral anticancer medications, heightening the challenge of ensuring optimal adherence to treatment. However, except for chronic myelogenous leukaemia or acute lymphoid leukaemia, the extent of non-adherence has rarely been investigated in outpatient settings, particularly for migrant population. With growing numbers of migrants in Belgium, identifying potential differences in drug use is essential. Also, previous research regarding social determinants of health highlight important disparities for migrant population. Difficulties in communication between health caregivers and patients from different cultural and ethnic backgrounds has been underlined. METHODS: Using a sequential mixed method design, the MADESIO protocol explores the adherence to oral anticancer medications in patients with haematological malignancies and among first and second generation migrants of varied origin. Conducted in the ambulatory setting, a first quantitative strand will measure adherence rates and associated risk factors in two sub-groups of patients with haematological malignancies (group A: first and second generation migrants and group B: non-migrants). The second qualitative strand of this study uses semi-structured interviews to address address the patients’ subjective meanings and understand the statistical associations observed in the quantitative study (strand one). MADESIO aims to provide a first assessment of whether and why migrants constitute a population at risk concerning adherence to oral anticancer medications. DISCUSSION: Our protocol is designed to provide a comprehensive understanding of adherence in a specific population. The methodological choices applied allow to explore adherence among patients from diverse linguistic and cultural backgrounds. A particular emphasis has been paid to minimize the biases and increase the reliability of the data collected. Easily reproductible, the MADESIO design may help healthcare services to screen adherence to Oral anticancer medications and to guide providers in choosing the best strategies to address medication adherence of migrants or minority diverse population. Public Library of Science 2021-06-24 /pmc/articles/PMC8224871/ /pubmed/34166438 http://dx.doi.org/10.1371/journal.pone.0253526 Text en © 2021 Michiels et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Study Protocol
Michiels, Sandra
Tricas-Sauras, Sandra
Dauvrin, Marie
Bron, Dominique
Kirakoya-Samadoulougou, Fati
A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol
title A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol
title_full A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol
title_fullStr A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol
title_full_unstemmed A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol
title_short A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol
title_sort mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: the madesio protocol
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224871/
https://www.ncbi.nlm.nih.gov/pubmed/34166438
http://dx.doi.org/10.1371/journal.pone.0253526
work_keys_str_mv AT michielssandra amixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol
AT tricassaurassandra amixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol
AT dauvrinmarie amixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol
AT brondominique amixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol
AT kirakoyasamadoulougoufati amixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol
AT michielssandra mixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol
AT tricassaurassandra mixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol
AT dauvrinmarie mixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol
AT brondominique mixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol
AT kirakoyasamadoulougoufati mixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol